Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 83

1.

Biphenyl-3-yl-4-[11C]methoxyphenylcarbamate.

Leung K.

Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004-2013.
2012 Dec 18 [updated 2013 Feb 21].

PMID:
23447835
[PubMed]
Books & Documents
2.

6-Hydroxy-[1,1'-biphenyl]-3-yl-cyclohexyl-[11C-carbonyl]carbamate.

Leung K.

Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004-2013.
2012 Oct 24 [updated 2013 Mar 21].

PMID:
23409303
[PubMed]
Books & Documents
3.

4-(3-((5-(2-[18F]Fluoroethoxy)pyridine-2-yl)oxy)benzylidene)-N-(pyridazin-3-yl)piperidine-1-carboxamide.

Leung K.

Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004-2013.
2012 Oct 20 [updated 2013 Feb 07].

PMID:
23409304
[PubMed]
Books & Documents
4.

PET imaging of fatty acid amide hydrolase in the brain: synthesis and biological evaluation of an 11C-labelled URB597 analogue.

Wyffels L, Muccioli GG, Kapanda CN, Labar G, De Bruyne S, De Vos F, Lambert DM.

Nucl Med Biol. 2010 Jul;37(5):665-75. doi: 10.1016/j.nucmedbio.2010.03.009. Epub 2010 May 6.

PMID:
20610171
[PubMed - indexed for MEDLINE]
5.

The fatty acid amide hydrolase inhibitor URB597 (cyclohexylcarbamic acid 3'-carbamoylbiphenyl-3-yl ester) reduces neuropathic pain after oral administration in mice.

Russo R, Loverme J, La Rana G, Compton TR, Parrott J, Duranti A, Tontini A, Mor M, Tarzia G, Calignano A, Piomelli D.

J Pharmacol Exp Ther. 2007 Jul;322(1):236-42. Epub 2007 Apr 5.

PMID:
17412883
[PubMed - indexed for MEDLINE]
Free Article
6.

Pharmacological activity of fatty acid amides is regulated, but not mediated, by fatty acid amide hydrolase in vivo.

Lichtman AH, Hawkins EG, Griffin G, Cravatt BF.

J Pharmacol Exp Ther. 2002 Jul;302(1):73-9.

PMID:
12065702
[PubMed - indexed for MEDLINE]
Free Article
7.

The fatty-acid amide hydrolase inhibitor URB597 does not affect triacylglycerol hydrolysis in rat tissues.

Clapper JR, Duranti A, Tontini A, Mor M, Tarzia G, Piomelli D.

Pharmacol Res. 2006 Nov;54(5):341-4. Epub 2006 Jun 29.

PMID:
16935521
[PubMed - indexed for MEDLINE]
8.

Characterization of the fatty acid amide hydrolase inhibitor cyclohexyl carbamic acid 3'-carbamoyl-biphenyl-3-yl ester (URB597): effects on anandamide and oleoylethanolamide deactivation.

Fegley D, Gaetani S, Duranti A, Tontini A, Mor M, Tarzia G, Piomelli D.

J Pharmacol Exp Ther. 2005 Apr;313(1):352-8. Epub 2004 Dec 3.

PMID:
15579492
[PubMed - indexed for MEDLINE]
Free Article
9.

The novel reversible fatty acid amide hydrolase inhibitor ST4070 increases endocannabinoid brain levels and counteracts neuropathic pain in different animal models.

Caprioli A, Coccurello R, Rapino C, Di Serio S, Di Tommaso M, Vertechy M, Vacca V, Battista N, Pavone F, Maccarrone M, Borsini F.

J Pharmacol Exp Ther. 2012 Jul;342(1):188-95. doi: 10.1124/jpet.111.191403. Epub 2012 Apr 18.

PMID:
22514334
[PubMed - indexed for MEDLINE]
Free Article
10.

Synthesis and preclinical evaluation of [11C-carbonyl]PF-04457845 for neuroimaging of fatty acid amide hydrolase.

Hicks JW, Parkes J, Sadovski O, Tong J, Houle S, Vasdev N, Wilson AA.

Nucl Med Biol. 2013 Aug;40(6):740-6. doi: 10.1016/j.nucmedbio.2013.04.008. Epub 2013 May 31.

PMID:
23731552
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Reduced anxiety-like behaviour induced by genetic and pharmacological inhibition of the endocannabinoid-degrading enzyme fatty acid amide hydrolase (FAAH) is mediated by CB1 receptors.

Moreira FA, Kaiser N, Monory K, Lutz B.

Neuropharmacology. 2008 Jan;54(1):141-50. Epub 2007 Jul 19.

PMID:
17709120
[PubMed - indexed for MEDLINE]
12.

The FAAH inhibitor URB597 efficiently reduces tyrosine hydroxylase expression through CB1 - and FAAH-independent mechanisms.

Bosier B, Muccioli GG, Lambert DM.

Br J Pharmacol. 2013 Jun;169(4):794-807. doi: 10.1111/j.1476-5381.2012.02208.x.

PMID:
22970888
[PubMed - in process]
Free PMC Article
14.

[11C]CURB: Evaluation of a novel radiotracer for imaging fatty acid amide hydrolase by positron emission tomography.

Wilson AA, Garcia A, Parkes J, Houle S, Tong J, Vasdev N.

Nucl Med Biol. 2011 Feb;38(2):247-53. doi: 10.1016/j.nucmedbio.2010.08.001.

PMID:
21315280
[PubMed - indexed for MEDLINE]
15.

Analgesic effects of fatty acid amide hydrolase inhibition in a rat model of neuropathic pain.

Jhaveri MD, Richardson D, Kendall DA, Barrett DA, Chapman V.

J Neurosci. 2006 Dec 20;26(51):13318-27.

PMID:
17182782
[PubMed - indexed for MEDLINE]
Free Article
16.

Pharmacological profile of the selective FAAH inhibitor KDS-4103 (URB597).

Piomelli D, Tarzia G, Duranti A, Tontini A, Mor M, Compton TR, Dasse O, Monaghan EP, Parrott JA, Putman D.

CNS Drug Rev. 2006 Spring;12(1):21-38. Review.

PMID:
16834756
[PubMed - indexed for MEDLINE]
17.

Modulation of opioids via protection of anandamide degradation by fatty acid amide hydrolase.

Haller VL, Stevens DL, Welch SP.

Eur J Pharmacol. 2008 Dec 14;600(1-3):50-8. doi: 10.1016/j.ejphar.2008.08.005. Epub 2008 Aug 20.

PMID:
18762181
[PubMed - indexed for MEDLINE]
18.

Cyclohexylcarbamic acid 3'- or 4'-substituted biphenyl-3-yl esters as fatty acid amide hydrolase inhibitors: synthesis, quantitative structure-activity relationships, and molecular modeling studies.

Mor M, Rivara S, Lodola A, Plazzi PV, Tarzia G, Duranti A, Tontini A, Piersanti G, Kathuria S, Piomelli D.

J Med Chem. 2004 Oct 7;47(21):4998-5008.

PMID:
15456244
[PubMed - indexed for MEDLINE]
19.

The endocannabinoid system as a target for novel anxiolytic and antidepressant drugs.

Gaetani S, Dipasquale P, Romano A, Righetti L, Cassano T, Piomelli D, Cuomo V.

Int Rev Neurobiol. 2009;85:57-72. doi: 10.1016/S0074-7742(09)85005-8.

PMID:
19607961
[PubMed - indexed for MEDLINE]
20.

Synthesis and quantitative structure-activity relationship of fatty acid amide hydrolase inhibitors: modulation at the N-portion of biphenyl-3-yl alkylcarbamates.

Mor M, Lodola A, Rivara S, Vacondio F, Duranti A, Tontini A, Sanchini S, Piersanti G, Clapper JR, King AR, Tarzia G, Piomelli D.

J Med Chem. 2008 Jun 26;51(12):3487-98. doi: 10.1021/jm701631z. Epub 2008 May 29. Erratum in: J Med Chem. 2009 Jan 8;52(1):224.

PMID:
18507372
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk